MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington’s disease gene carriers

H. Wilson, F. Niccolini, S. Haider, T. Reis Marques, G. Pagano, C. Coello, S. Natesan, S. Kapur, E.A. Rabiner, R.N. Gunn, S.J. Tabrizi, M. Politis (London, United Kingdom)

Meeting: 2016 International Congress

Abstract Number: 1100

Keywords: Magnetic resonance imaging(MRI), Positron emission tomography(PET)

Session Information

Date: Wednesday, June 22, 2016

Session Title: Ataxiz, Choreas

Session Time: 12:00pm-1:30pm

Objective: Using positron emission tomography (PET) with [11C]IMA107, we investigated the in vivo expression of PDE10A in extra-striatal regions in a cohort of 12 early premanifest HD gene carriers.

Background: Huntington’s disease (HD) is a monogenic, progressive and fatal neurodegenerative disorder with an underlying pathology involving the toxic effect of mutant huntingtin protein primarily in striatal and cortical neurons. Phosphodiesterase 10A (PDE10A) regulates intracellular signalling cascades, thus having a key role in promoting neuronal survival. Altered PDE10A levels has previous been reported within basal ganglia regions in far and near onset premanifest and manifest HD gene carriers.

Methods: Image processing and kinetic modelling was carried out using MIAKATTM. Parametric images of [11C]IMA107 non-displaceable binding potential (BPND) were generated from the dynamic [11C]IMA107 scans using implementation of the simplified reference tissue model with the cerebellum as the reference tissue for nonspecific binding. We set a threshold criterion for meaningful quantification for extra-striatal [11C]IMA107 BPND at 0.30 in healthy control data.

Results: The occipital pole, occipital fusiform gyrus, insular cortex, frontal operculum cortex and posterior cingulate gyrus met this criterion, were designated as extra-striatal regions-of-interest (ROIs), and subsequent analyses were carried out. MRI based volumetric analysis showed no atrophy in extra-striatal ROIs. We found significant differences in mean extra-striatal ROIs [11C]IMA107 BPND between the HD gene carriers and the healthy controls (P=0.037). HD gene carriers had significantly lower mean 11C]IMA107 BPND within the insular cortex (P=0.025; -25%) and occipital fusiform gyrus (P=0.010; -42%) compared to healthy controls.

Conclusions: Insula and occipital fusiform gyrus are important brain areas for the regulation of cognitive and limbic function that is impaired in HD. Our findings suggest that dysregulation of PDE10A mediated intracellular signalling could be an early phenomenon in the course of HD with relevance also for extra-striatal brain areas regulating cognitive and limbic function.

To cite this abstract in AMA style:

H. Wilson, F. Niccolini, S. Haider, T. Reis Marques, G. Pagano, C. Coello, S. Natesan, S. Kapur, E.A. Rabiner, R.N. Gunn, S.J. Tabrizi, M. Politis. Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington’s disease gene carriers [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/loss-of-extra-striatal-phosphodiesterase-10a-expression-in-early-premanifest-huntingtons-disease-gene-carriers/. Accessed May 20, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/loss-of-extra-striatal-phosphodiesterase-10a-expression-in-early-premanifest-huntingtons-disease-gene-carriers/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Safety and Tolerability of a Ketone Supplement in Parkinson's Disease
  • Successful external defibrillation in a patient with bilateral deep brain stimulation
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley